Amalgamated Bank Intellia Therapeutics, Inc. Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 3,514 shares of NTLA stock, worth $35,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,514

Previous 3,514 -0.0%

Holding current value

$35,772

Previous $32,000 87.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$7.11 - $12.8 $2,609 - $4,697	367 Added 11.66%	3,514 $25,000
Q2 2024 Aug 12, 2024	BUY	$20.02 - $27.22 $2,822 - $3,838	141 Added 4.69%	3,147 $70,000
Q1 2024 Apr 23, 2024	SELL	$23.82 - $32.8 $132,701 - $182,728	-5,571 Reduced 64.95%	3,006 $83,000
Q4 2023 Feb 06, 2024	SELL	$23.16 - $32.34 $17,022 - $23,769	-735 Reduced 7.89%	8,577 $262,000
Q3 2023 Nov 08, 2023	BUY	$31.62 - $45.78 $6,924 - $10,025	219 Added 2.41%	9,312 $294,000
Q2 2023 Aug 11, 2023	SELL	$34.58 - $46.03 $58,371 - $77,698	-1,688 Reduced 15.66%	9,093 $370,000
Q1 2023 May 02, 2023	SELL	$33.3 - $44.82 $78,055 - $105,058	-2,344 Reduced 17.86%	10,781 $402,000
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $58,881 - $111,149	1,773 Added 15.62%	13,125 $458,000
Q3 2022 Nov 09, 2022	BUY	$53.92 - $71.7 $11,970 - $15,917	222 Added 1.99%	11,352 $635,000
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $11,162 - $22,100	-290 Reduced 2.54%	11,130 $576,000
Q1 2022 Jun 30, 2022	SELL	$58.27 - $118.99 $49,820 - $101,736	-855 Reduced 6.97%	11,420 $830,000
Q4 2021 Feb 15, 2022	BUY	$100.76 - $138.36 $3,022 - $4,150	30 Added 0.24%	12,275 $1.45 Million
Q3 2021 Oct 29, 2021	BUY	$132.37 - $176.78 $24,091 - $32,173	182 Added 1.51%	12,245 $1.64 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $258,922 - $688,603	4,253 Added 54.46%	12,063 $1.95 Million
Q1 2021 May 13, 2021	SELL	$46.59 - $83.68 $1,164 - $2,092	-25 Reduced 0.32%	7,810 $627,000
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $147,533 - $497,757	7,835 New	7,835 $426,000

Others Institutions Holding NTLA

# of Institutions

337

Shares Held

100M

Call Options Held

2.14M

Put Options Held

998K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $774M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Intellia Therapeutics, Inc. Transaction History